Global Anti-Obesity Prescription Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Obesity Prescription Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Obesity Prescription Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Obesity Prescription Drugs by Country/Region, 2017, 2022 & 2028

2.2 Anti-Obesity Prescription Drugs Segment by Type

2.2.1 Pediatric

2.2.2 Adult

2.3 Anti-Obesity Prescription Drugs Sales by Type

2.3.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Obesity Prescription Drugs Sale Price by Type (2017-2022)

2.4 Anti-Obesity Prescription Drugs Segment by Application

2.4.1 Hospitals Pharmacies

2.4.2 Retail Pharmacies

2.4.3 E-commerce

2.5 Anti-Obesity Prescription Drugs Sales by Application

2.5.1 Global Anti-Obesity Prescription Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Obesity Prescription Drugs Sale Price by Application (2017-2022)

3 Global Anti-Obesity Prescription Drugs by Company

3.1 Global Anti-Obesity Prescription Drugs Breakdown Data by Company

3.1.1 Global Anti-Obesity Prescription Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Obesity Prescription Drugs Sales Market Share by Company (2020-2022)

3.2 Global Anti-Obesity Prescription Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Obesity Prescription Drugs Revenue by Company (2020-2022)

3.2.2 Global Anti-Obesity Prescription Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Obesity Prescription Drugs Sale Price by Company

3.4 Key Manufacturers Anti-Obesity Prescription Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Obesity Prescription Drugs Product Location Distribution

3.4.2 Players Anti-Obesity Prescription Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Obesity Prescription Drugs by Geographic Region

4.1 World Historic Anti-Obesity Prescription Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Obesity Prescription Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Obesity Prescription Drugs Annual Revenue by Geographic Region

4.2 World Historic Anti-Obesity Prescription Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Obesity Prescription Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Obesity Prescription Drugs Annual Revenue by Country/Region

4.3 Americas Anti-Obesity Prescription Drugs Sales Growth

4.4 APAC Anti-Obesity Prescription Drugs Sales Growth

4.5 Europe Anti-Obesity Prescription Drugs Sales Growth

4.6 Middle East & Africa Anti-Obesity Prescription Drugs Sales Growth

5 Americas

5.1 Americas Anti-Obesity Prescription Drugs Sales by Country

5.1.1 Americas Anti-Obesity Prescription Drugs Sales by Country (2017-2022)

5.1.2 Americas Anti-Obesity Prescription Drugs Revenue by Country (2017-2022)

5.2 Americas Anti-Obesity Prescription Drugs Sales by Type

5.3 Americas Anti-Obesity Prescription Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Obesity Prescription Drugs Sales by Region

6.1.1 APAC Anti-Obesity Prescription Drugs Sales by Region (2017-2022)

6.1.2 APAC Anti-Obesity Prescription Drugs Revenue by Region (2017-2022)

6.2 APAC Anti-Obesity Prescription Drugs Sales by Type

6.3 APAC Anti-Obesity Prescription Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Obesity Prescription Drugs by Country

7.1.1 Europe Anti-Obesity Prescription Drugs Sales by Country (2017-2022)

7.1.2 Europe Anti-Obesity Prescription Drugs Revenue by Country (2017-2022)

7.2 Europe Anti-Obesity Prescription Drugs Sales by Type

7.3 Europe Anti-Obesity Prescription Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Obesity Prescription Drugs by Country

8.1.1 Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Obesity Prescription Drugs Sales by Type

8.3 Middle East & Africa Anti-Obesity Prescription Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Obesity Prescription Drugs

10.3 Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

10.4 Industry Chain Structure of Anti-Obesity Prescription Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Obesity Prescription Drugs Distributors

11.3 Anti-Obesity Prescription Drugs Customer

12 World Forecast Review for Anti-Obesity Prescription Drugs by Geographic Region

12.1 Global Anti-Obesity Prescription Drugs Market Size Forecast by Region

12.1.1 Global Anti-Obesity Prescription Drugs Forecast by Region (2023-2028)

12.1.2 Global Anti-Obesity Prescription Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Obesity Prescription Drugs Forecast by Type

12.7 Global Anti-Obesity Prescription Drugs Forecast by Application

13 Key Players Analysis

13.1 F Hoffmann La Roche Ltd

13.1.1 F Hoffmann La Roche Ltd Company Information

13.1.2 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offered

13.1.3 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 F Hoffmann La Roche Ltd Main Business Overview

13.1.5 F Hoffmann La Roche Ltd Latest Developments

13.2 Orexigen Therapeutics

13.2.1 Orexigen Therapeutics Company Information

13.2.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offered

13.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Orexigen Therapeutics Main Business Overview

13.2.5 Orexigen Therapeutics Latest Developments

13.3 Novo Nordisk A/s

13.3.1 Novo Nordisk A/s Company Information

13.3.2 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offered

13.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Novo Nordisk A/s Main Business Overview

13.3.5 Novo Nordisk A/s Latest Developments

13.4 Arena Pharmaceuticals

13.4.1 Arena Pharmaceuticals Company Information

13.4.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offered

13.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Arena Pharmaceuticals Main Business Overview

13.4.5 Arena Pharmaceuticals Latest Developments

13.5 Glaxosmithkline

13.5.1 Glaxosmithkline Company Information

13.5.2 Glaxosmithkline Anti-Obesity Prescription Drugs Product Offered

13.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Glaxosmithkline Main Business Overview

13.5.5 Glaxosmithkline Latest Developments

13.6 Vivus

13.6.1 Vivus Company Information

13.6.2 Vivus Anti-Obesity Prescription Drugs Product Offered

13.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Vivus Main Business Overview

13.6.5 Vivus Latest Developments

13.7 Boehringer Ingelheim

13.7.1 Boehringer Ingelheim Company Information

13.7.2 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offered

13.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Boehringer Ingelheim Main Business Overview

13.7.5 Boehringer Ingelheim Latest Developments

13.8 Alizyme

13.8.1 Alizyme Company Information

13.8.2 Alizyme Anti-Obesity Prescription Drugs Product Offered

13.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Alizyme Main Business Overview

13.8.5 Alizyme Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-Obesity Prescription Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Obesity Prescription Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Pediatric

Table 4. Major Players of Adult

Table 5. Global Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 6. Global Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)

Table 7. Global Anti-Obesity Prescription Drugs Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2022)

Table 9. Global Anti-Obesity Prescription Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 11. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

Table 12. Global Anti-Obesity Prescription Drugs Revenue by Application (2017-2022)

Table 13. Global Anti-Obesity Prescription Drugs Revenue Market Share by Application (2017-2022)

Table 14. Global Anti-Obesity Prescription Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Anti-Obesity Prescription Drugs Sales by Company (2020-2022) & (K Units)

Table 16. Global Anti-Obesity Prescription Drugs Sales Market Share by Company (2020-2022)

Table 17. Global Anti-Obesity Prescription Drugs Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anti-Obesity Prescription Drugs Revenue Market Share by Company (2020-2022)

Table 19. Global Anti-Obesity Prescription Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Anti-Obesity Prescription Drugs Producing Area Distribution and Sales Area

Table 21. Players Anti-Obesity Prescription Drugs Products Offered

Table 22. Anti-Obesity Prescription Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anti-Obesity Prescription Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Anti-Obesity Prescription Drugs Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anti-Obesity Prescription Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anti-Obesity Prescription Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anti-Obesity Prescription Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Anti-Obesity Prescription Drugs Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anti-Obesity Prescription Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anti-Obesity Prescription Drugs Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 34. Americas Anti-Obesity Prescription Drugs Sales Market Share by Country (2017-2022)

Table 35. Americas Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anti-Obesity Prescription Drugs Revenue Market Share by Country (2017-2022)

Table 37. Americas Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 38. Americas Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)

Table 39. Americas Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 40. Americas Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

Table 41. APAC Anti-Obesity Prescription Drugs Sales by Region (2017-2022) & (K Units)

Table 42. APAC Anti-Obesity Prescription Drugs Sales Market Share by Region (2017-2022)

Table 43. APAC Anti-Obesity Prescription Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anti-Obesity Prescription Drugs Revenue Market Share by Region (2017-2022)

Table 45. APAC Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 46. APAC Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)

Table 47. APAC Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 48. APAC Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

Table 49. Europe Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 50. Europe Anti-Obesity Prescription Drugs Sales Market Share by Country (2017-2022)

Table 51. Europe Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country (2017-2022)

Table 53. Europe Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 54. Europe Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)

Table 55. Europe Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 56. Europe Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anti-Obesity Prescription Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anti-Obesity Prescription Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anti-Obesity Prescription Drugs

Table 66. Key Market Challenges & Risks of Anti-Obesity Prescription Drugs

Table 67. Key Industry Trends of Anti-Obesity Prescription Drugs

Table 68. Anti-Obesity Prescription Drugs Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anti-Obesity Prescription Drugs Distributors List

Table 71. Anti-Obesity Prescription Drugs Customer List

Table 72. Global Anti-Obesity Prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Anti-Obesity Prescription Drugs Sales Market Forecast by Region

Table 74. Global Anti-Obesity Prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anti-Obesity Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Anti-Obesity Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anti-Obesity Prescription Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Anti-Obesity Prescription Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anti-Obesity Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Anti-Obesity Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anti-Obesity Prescription Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Anti-Obesity Prescription Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anti-Obesity Prescription Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Anti-Obesity Prescription Drugs Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anti-Obesity Prescription Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anti-Obesity Prescription Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 92. F Hoffmann La Roche Ltd Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 93. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offered

Table 94. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. F Hoffmann La Roche Ltd Main Business

Table 96. F Hoffmann La Roche Ltd Latest Developments

Table 97. Orexigen Therapeutics Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 98. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offered

Table 99. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Orexigen Therapeutics Main Business

Table 101. Orexigen Therapeutics Latest Developments

Table 102. Novo Nordisk A/s Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 103. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offered

Table 104. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Novo Nordisk A/s Main Business

Table 106. Novo Nordisk A/s Latest Developments

Table 107. Arena Pharmaceuticals Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 108. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offered

Table 109. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Arena Pharmaceuticals Main Business

Table 111. Arena Pharmaceuticals Latest Developments

Table 112. Glaxosmithkline Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 113. Glaxosmithkline Anti-Obesity Prescription Drugs Product Offered

Table 114. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Glaxosmithkline Main Business

Table 116. Glaxosmithkline Latest Developments

Table 117. Vivus Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 118. Vivus Anti-Obesity Prescription Drugs Product Offered

Table 119. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Vivus Main Business

Table 121. Vivus Latest Developments

Table 122. Boehringer Ingelheim Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 123. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offered

Table 124. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Boehringer Ingelheim Main Business

Table 126. Boehringer Ingelheim Latest Developments

Table 127. Alizyme Basic Information, Anti-Obesity Prescription Drugs Manufacturing Base, Sales Area and Its Competitors

Table 128. Alizyme Anti-Obesity Prescription Drugs Product Offered

Table 129. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Alizyme Main Business

Table 131. Alizyme Latest Developments

List of Figures

Figure 1. Picture of Anti-Obesity Prescription Drugs

Figure 2. Anti-Obesity Prescription Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Obesity Prescription Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-Obesity Prescription Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Obesity Prescription Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Pediatric

Figure 10. Product Picture of Adult

Figure 11. Global Anti-Obesity Prescription Drugs Sales Market Share by Type in 2021

Figure 12. Global Anti-Obesity Prescription Drugs Revenue Market Share by Type (2017-2022)

Figure 13. Anti-Obesity Prescription Drugs Consumed in Hospitals Pharmacies

Figure 14. Global Anti-Obesity Prescription Drugs Market: Hospitals Pharmacies (2017-2022) & (K Units)

Figure 15. Anti-Obesity Prescription Drugs Consumed in Retail Pharmacies

Figure 16. Global Anti-Obesity Prescription Drugs Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 17. Anti-Obesity Prescription Drugs Consumed in E-commerce

Figure 18. Global Anti-Obesity Prescription Drugs Market: E-commerce (2017-2022) & (K Units)

Figure 19. Global Anti-Obesity Prescription Drugs Sales Market Share by Application (2017-2022)

Figure 20. Global Anti-Obesity Prescription Drugs Revenue Market Share by Application in 2021

Figure 21. Anti-Obesity Prescription Drugs Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Anti-Obesity Prescription Drugs Revenue Market Share by Company in 2021

Figure 23. Global Anti-Obesity Prescription Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Anti-Obesity Prescription Drugs Revenue Market Share by Geographic Region in 2021

Figure 25. Global Anti-Obesity Prescription Drugs Sales Market Share by Region (2017-2022)

Figure 26. Global Anti-Obesity Prescription Drugs Revenue Market Share by Country/Region in 2021

Figure 27. Americas Anti-Obesity Prescription Drugs Sales 2017-2022 (K Units)

Figure 28. Americas Anti-Obesity Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 29. APAC Anti-Obesity Prescription Drugs Sales 2017-2022 (K Units)

Figure 30. APAC Anti-Obesity Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 31. Europe Anti-Obesity Prescription Drugs Sales 2017-2022 (K Units)

Figure 32. Europe Anti-Obesity Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Anti-Obesity Prescription Drugs Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Anti-Obesity Prescription Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Americas Anti-Obesity Prescription Drugs Sales Market Share by Country in 2021

Figure 36. Americas Anti-Obesity Prescription Drugs Revenue Market Share by Country in 2021

Figure 37. United States Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Anti-Obesity Prescription Drugs Sales Market Share by Region in 2021

Figure 42. APAC Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2021

Figure 43. China Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Anti-Obesity Prescription Drugs Sales Market Share by Country in 2021

Figure 50. Europe Anti-Obesity Prescription Drugs Revenue Market Share by Country in 2021

Figure 51. Germany Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share by Country in 2021

Figure 58. Egypt Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Anti-Obesity Prescription Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Anti-Obesity Prescription Drugs in 2021

Figure 64. Manufacturing Process Analysis of Anti-Obesity Prescription Drugs

Figure 65. Industry Chain Structure of Anti-Obesity Prescription Drugs

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles